St. Jude Medical Shows Commitment to Cardiac Advancements With Comprehensive Clinical Evidence Program During Heart Rhythm 2014

Published: May 05, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, is participating in Heart Rhythm 2014, the Heart Rhythm Society’s Annual Scientific Sessions. Clinical evidence about the company’s cardiac rhythm management and ablation technologies will be provided in 38 sessions, including three late-breaking clinical trial sessions. The company’s latest technologies will be on display May 7-10 in booth 1002 at the Moscone Convention Center in San Francisco.

Help employers find you! Check out all the jobs and post your resume.

Back to news